Our Areas of Focus
CureGene focuses on two major therapeutic areas: cardio-cerebrovascular and antivirals.
Our mission is to develop state-of-the-art medications that address unmet medical needs and remain competitive in the global market.
News
-
Shanghai Curegene presented Phase I results of CG-0255 on ESC Congress 2024, London, disclosing the potential clinical application of the innovative antiplatelet drug
-
CureGene Achieves First-Dose Milestone for Antiplatelet Drug CG-0255 IV Formulation in US Clinical Trial
-
CureGene Announces Completion of Series B Fund Raising accelerating Global Clinical Development